Evidence map›Paper›PMID 23299731›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2013

Chromatographic analysis of the Escherichia coli polysialic acid capsule.

Susan M Steenbergen, Eric R Vimr

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Susan M SteenbergenDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Eric R Vimr
University of Illinois Urbana-Champaign · US

Funding

Regulation of the Poly Sialic Virulence FactorR01AI042015 · NIAID · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI VIMR, ERIC ROSS · 1998 to 2014
$2.6M
Regulation of the Poly Sialic Virulence FactorR56AI042015 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI VIMR, ERIC ROSS · 2009 to 2009
$238k
NIAID NIH HHS AI042015NIAID NIH HHS R01 AI042015NIAID NIH HHS R56 AI042015
6 · The paper itself

Abstract

Polysialic acid capsules are the major virulence factors in Escherichia coliK1, K92, and groups B and C meningococci. The sialic acid monomers (2-keto-3-deoxy-5-acetamido-7,8,9-D-glycero-D-galacto-nonulosonic acids) comprising these homopolymeric polysaccharide chains can be selectively modified with 1,2-diamino-4,5-methylenedioxy-benzene to produce highly fluorescent quinoxalinone derivatives distinguished by their elution times during reverse phase chromatography. Here, we describe methods to release the constituent capsular polysialic acid monomers, and to detect and quantify them by sensitive fluorometry. There are relatively few 2-keto acids in bacteria, making it possible to rapidly analyze samples even without prior purification of capsular polysaccharides.

Indexed as

Chromatography, LiquidEscherichia coliFluorescent DyesReference StandardsSialic AcidsFluorescent Dyespolysialic acidSialic Acids

Identifiers

PMID23299731
PMCPMC4085740
OpenAlexW35231224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.